Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private Equity
Bluebird Bio, an organization that steered three gene therapies to FDA approval however struggled to commercialize them, has discovered the ...
Bluebird Bio, an organization that steered three gene therapies to FDA approval however struggled to commercialize them, has discovered the ...
Novartis is increasing its prospects in cardiometabolic illness by putting a deal to accumulate Anthos Therapeutics, an organization in pivotal ...
A notable marriage is going on on the earth of digital well being: Transcarent has claimed Accolade for $621 million. ...
Avid Bioservices, a contract growth manufacturing group (CDMO) specializing in biologic medication, goes personal in an M&A deal that values ...
Neuroscience drug developer Lundbeck is increasing its scope to epilepsy through the $2.6 billion acquisition of Longboard Prescribed drugs, an ...
A examine from Yale College at the moment in JAMA Community Open reveals substantial safety by the preventive drug nirsevimab...
Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.
Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.